Ligand's Partner Novan Submits New Drug Application to the U.S. FDA for Berdazimer Gel, 10.3% (SB206) for the Treatment of Molluscum Contagiosum
Novan Submits New Drug Application to the U.S. FDA for Berdazimer Gel, 10.3% (SB206) for the Treatment of Molluscum Contagiosum
Aquestive Therapeutics Provides Business Update and Outlines Key 2023 Objectives
Global Spinal Muscular Atrophy Treatment Market Report 2022: Growing R&D Activities for Treatments Boosts Sector - ResearchAndMarkets.com
BiondVax's Innovative Inhaled COVID-19 Therapy Virtually Eliminated SARS-COV-2 Virus in Preclinical In Vivo Study
Global Spinal Muscular Atrophy Treatment Market Report 2022: Increasing Reimbursement Access To Patients Bolsters Growth
MediciNova to Meet with U.S. FDA to Discuss Clinical Development of a Parenteral Formulation of MN-166 (ibudilast)
Provention Bio Announces Appointment of Rita Jain, M.D., to Board of Directors
MedinCell announces positive results for the SAIVE clinical study in prevention of Covid-19 infection in a contact-based population
Bioethics International Publishes New Index to Score Pharma Companies on Clinical Trial Diversity in BMJ Medicine
 14   15   16   17   18     19    20   21   22   23   24 
 <<   <   >   >>